Viral Risks Associated with Blood Transfusion

Photochemistry and Photobiology

Volumn 65, Issue 3, 1997, Pages 428-431

  Sloand, Elaine M ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Bldg 31 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031105482     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1997.tb08583.x     Document Type: Conference Paper

References (55)

1. Savarit, D., K. M. De Cock, R. Schutz, S. Konate, E. Lackritz and A. Bondurand (1992) Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city. Br. Med. J. 305, 498-501.
2. Alter, H. J. (1987) You'll wonder where the yellow went: a 15-year retrospective of posttransfusion hepatitis. In Transfusion-Transmitted Viral Diseases (Edited by S. B. Moore), pp. 53-86. American Association of Blood Banks, Arlington, VA.
3. Centers for Disease Control (1990) Public Health Service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 40, 1-17.
4. Hoofnagle, J. H. (1990) Posttransfusion hepatitis B. Transfusion 30, 384-386.
5. Lai, M. E., P. Farci, A. Figus, A. Balestrieri, M. Arnone and G. N. Vyas (1989) Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood 73, 17-19.
6. Bréchot, C., F. Degos, C. Lugassy, V. Thiers, S. Zafrani, D. Franco, H. Bismuth, C. Trepo, J. P. Benhamou, J. Wands, K. Isselbacher, P. Tiolais and P. Berthelot (1985) Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N. Engl. J. Med. 312, 270-276.
7. Shin, L. N., J. C. Sheu, J. T. Wang, G. T. Huang, P. M. Yang, H. S. Lee, J. L. Sung, T. H. Wang and D. S. Chen (1990) Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction. J. Med. Virol. 32, 257-260.
8. Bréchot, C., D. Kremsdorf, P. Paterlini and V. Thiers (1991) Hepatitis B virus DNA in HBsAg-negative patients. Molecular characterization and clinical implications. J. Hepatol. 13, S49-S55.
9. Sun, C. F., C. C. Pao, S. Y. Wu and Y. F. Liaw (1988) Screening for hepatitis B virus in healthy blood donors by molecular DNA hybridization analysis. J. Clin. Microbiol. 26, 1848-1852.
10. Thiers, V., E. Nakajima, D. Kremsdorf, D. Mack, H. Schellekens, F. Driss, A. Goudeau, J. Wands, J. Sninsky, P. Tiollais and C. Brechot (1988) Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 2, 1273-1276.
11. Lander, J. J., G. L. Gitnick, L. H. Gelb and R. D. Aach (1978) Anticore antibody screening of transfused blood. Vox Sang. 34, 77-80.
12. Stevens, C. E., R. D. Aach, B. Hollinger, J. W. Mosley, W. Szmuness, R. Kahn, J. Werch and V. Edwards (1984) Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the transfusion-transmitted viruses study. Ann. Intern. Med. 101, 733-738.
13. Hoofnagle, J. H., L. B. Seeff, Z. B. Bales, H. J. Zimmerman and the Veterans Administration Hepatitis Cooperative Study Group (1978) Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N. Engl. J. Med. 298, 1379-1383.
14. Schreiber, G. B., M. P. Busch, S. H. Kleinman and J. J. Korelitz for the Retrovirus Epidemiology Epidemiology Donor Study (1996) The risk of transfusion-transmitted viral infections. N. Engl. J. Med. 334, 1685-1690.
15. Alter, H. J., R. H. Purcell, P. V. Holland, S. M. Feinstone, A. G. Morrow and Y. Moritsugu (1975) Clinical and serological analysis of transfusion-associated hepatitis. Lancet 2, 838-841.
16. Alter, H. J., R. H. Purcell, P. V. Holland, D. W. Alling and D. E. Koziol (1981) Donor transaminase and recipient hepatitis. Impact on blood transfusion services. J. Am. Med. Assoc. 246, 630-634.
17. Aach, R. D., W. Szmuness and J. W. Mosley (1981) Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The transfusion-transmitted viruses study. N. Engl. J. Med. 304, 989-994.
18. Koziol, D. E., P. V. Holland, D. W. Ailing, J. C. Melpolder, R. E. Solomon, R. H. Purcell, L. M. Hudson, F. J. Shoup, H. Krakauer and H. J. Alter (1986) Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann. Intern. Med. 104, 488-495.
19. Japanese Red Cross Non-A, Non-B Hepatitis Research Group (1991) Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 338, 1040-1041.
20. Esteban, J. I., J. C. López-Talavera, J. Genescà, P. Madoz, L. Viladomiu, E. Muniz, C. Martin-Vega, M. Resell, H. Allende, X. Vidal, A. Gonzalez, J. M. Hernandez, R. Esteban and J. Guardia (1991) High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann. Intern. Med. 115, 443-449.
21. Aach, R. D., C. E. Stevens, B. Hollinger, J. W. Mosley, D. A. Peterson, P. E. Taylor, R. G. Johnson, L. H. Barbosa and G. J. Nemo (1991) Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N. Engl. J. Med. 325, 1325-1329.
22. van der Poel, C. L., H. T. M. Cuypers, H. W. Reesink and A. J. Weiner (1991) Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337, 317-319.
23. Alter, H. J., G. E. Tegtmeier, B. W. Jett, S. Quan, J. W. Shih, W. L. Bayer and A. Polito (1991) The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors. Transfusion 31, 771-776.
24. Quer, J., J. C. López-Talavera and J. I. Esteban (1991) Serum HCV-RNA in anti-HCV-reactive donors according to RIBA-2, liver histology and infectivity. J. Hepatol. 13, S62.
25. Esteban, J. I., J. C. López-Talavera and J. Genescà (1991) High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann. Intern. Med. 115, 443-449.
26. Farci, P., H. J. Alter, D. Wong, R. H. Miller, J. W. Shih, B. Jet and R. H. Purcell (1991) A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N. Engl. J. Med. 325, 98-104.
27. Esteban, J. I., A. González and J. M. Hernández (1990) Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N. Engl. J. Med. 323, 1107-1112.
28. Donahue, J. G., A. Munoz, P. M. Ness, D. E. Brown, D. H. Yawn, H. A. McAllister, B. A. Reitz and K. E. Nelson (1992) The declining risk of posttransfusion hepatitis C virus infection. N. Engl. J. Med. 327, 369-373.
29. Okochi, K., H. Sato and Y. Hinuma (1984) A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 46, 245-253.
30. Manns, A., R. J. Wilks, E. L. Murphy, G. Haynes, J. P. Figueroa, M. Barnett, B. Hanchard and W. A. Blattner (1992) A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int. J. Cancer 51, 886-891.
31. Kleinman, S., J. Allain and H. Lee (1991) HTLV transmission by transfusion: serology and PCR results. Transfusion 31, 41S.
32. Transfusion Safety Study (TSS) Group (1991) Transfusion-transmitted HTLV-I and II: infectivity and clinical consequences in donors and recipients. Transfusion 31, 41S.
33. Feigal, E., E. Murphy and K. Vranizan (1991) Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J. Infect. Dis. 164, 36-42.
34. Wiktor, S. Z., E. J. Pate, S. H. Weiss, R. S. Gohd, P. Correa, E. T. Fontham, B. Hanchard, R. J. Biggar and W. A. Blattner (1991) Sensitivity of HTLV-I antibody assays for HTLV-II. Lancet 338, 512-513.
35. Hjelle, B., O. Appenzeller, R. Mills, S. Alexander, N. Torrez-Martinez, R. Jahnke and G. Ross (1993) Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339, 645-646.
36. Murphy, E. L., J. W. Engstrom, K. Miller, R. A. Sacher, M. P. Busch and C. G. Hollingsworth (1993) HTLV-II associated myelopathy in 43-year-old woman. Lancet 341, 757-758.
37. Jacobson, S., T. Lehky, M. Nishimura, S. Robinson, D. E. McFarlin and S. Dhib-Jalbut (1993) Isolation of HTLV-II from a patient with chronic progressive neurological disease clinically indistinguishable from HTLV-I - associated myelopathy/tropical spastic paraparesis. Ann. Neurol. 33, 392-396.
38. Murphy, E. L., B. Hanchard, J. P. Figueroa, W. N. Gibbs, W. S. Lofters, M. Campbell, J. J. Goedert and W. A. Blattner (1989) Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus Type 1. Int. J. Cancer 43, 250-253.
39. Busch, M. P., M. J. Young, S. M. Samson, J. W. Mosley, J. W. Ward, H. A. Perkins and the Transfusion Safety Study Group (1991) Risk of human immunodeficiency virus transmission by blood transfusions prior to the implementation of HIV antibody screening in the San Francisco Bay Area. Transfusion 31, 4-11.
40. Nelson, K., J. G. Donahue, A. Munoz, N. D. Cohen, P. M. Ness, A. Teague, V. A. Stambolis, D. H. Yawn, B. Callicott, H. McAllister, B. A. Reitz and H. Lee (1992) Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann. Int. Med. 117, 554-559.
41. Busch, M. P., B. E. Eble, H. Khayam-Bashi, D. Heilbron, E. L. Murphy, S. Kwok, J. Sninsky, H. A. Perkins and G. N. Vyas (1991) Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N. Engl. J. Med. 325, 1-5.
42. Donegan, E., B. A. Lenes, P. A. Tomasulo, J. W. Mosely and the Transfusion Safety Study Group (1990) Transmission of HIV-1 by component type and duration of shelf storage before transfusion. Transfusion 30, 851-852.
43. Horsburgh, C. R., C. Y. Ou, J. Jason, S. D. Holmberg, I. M. Longini, C. Schable, K. M. Mayer, A. R. Lifson, G. Schochetman, J. W. Ward, G. W. Rutherford, B. L. Evatt, G. R. Seage and H. W. Jaffe (1989) Duration of human immunodeficiency virus infection before detection of the antibody. Lancet 2, 637-640.
44. Lefrère, J. J., M. Mariotti, D. Vittecoq and B. Noel (1991) No evidence of frequent human immunodeficiency virus type 1 infection in seronegative at-risk individuals. Transfusion 31, 205-211.
45. Esteban, J. I., J.W.-K. Shih, C.-C. Tai, A. J. Bodner, J. W. D. Kay and H. J. Alter (199?) Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet 2, 1083-1086.
46. Mariotti, M., J. J. Lefrère and B. Noel (1990) DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals. AIDS 4, 633-637.
47. Lefrere, J. J., M. Mariotti, A. M. Courouce, P. Rouger, C. Salmon and D. Vittecoq (1990) Polymerase chain reaction testing of HIV-1 seronegative at-risk individuals. Lancet 335, 1400-1401.
48. Busch, M. P. (1995) Testing blood donors for HIV: current controversies. Immun. Invest. 24, 147-154.
49. Busch, M. P. (1994) HIV and blood transfusions: focus on seroconversion. Vox Sang. S3, 13-18.
50. Krech, W. (1973) Complement fixing antibodies against cytomegalovirus in different parts of the world. Bull. WHO 49, 103-106.
51. Bowden, R. A. and M. H. Sayers (1990) The risk of transmitting cytomegalovirus infection by fresh frozen plasma. Transfusion 30, 762-763.
52. de Graan-Hentzen, Y. C. E., J. W. Gratama, G. C. Mudde et al. (1989) Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 29, 757-760.
53. Gilbert, G. L., K. Hayes, I. L. Hudson, J. James and the Neonatal Cytomegalovirus Infection Study Group (1989) Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Lancet 1, 1228-1231.
54. Sayers, M. H., K. C. Anderson and L. T. Goodnough (1992) Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann. Intern. Med. 116, 55-62.
55. Bowden, R. A. (1992) Cytomegalovirus: transmission by blood components and measures of prevention. In Blood Safety: Current Challenges (Edited by S. J. Nance), pp. 201-211. American Association of Blood Banks, Bethesda, MD.